LEP and metabolic dysfunction-associated steatohepatitis: Serum leptin showed a good performance again when distinguishing controls (both non-obese and obese) from NAFLD patients (both NAFL and NASH), with AUROC = 0.83 (95%, CI 0.74–0.91; p < 0.0001).